Literature DB >> 17875560

Diagnosis and treatment of depression following acquired brain injury: a comparison of practice in the UK and the Netherlands.

Anne Margreet Knottnerus1, Tabitha Turner-Stokes, F B van de Weg, L Heijnen, G J Lankhorst, Lynne Turner-Stokes.   

Abstract

OBJECTIVE: To describe and compare current practice in diagnosis and treatment of depression following acquired brain injury in two countries (UK and the Netherlands) which have different sets of guidelines. SETTING AND
DESIGN: A cross-sectional survey of reported practice among rehabilitation physician members of the British and Dutch specialist societies.
METHODS: A 12-item postal questionnaire was sent to 496 rehabilitation physicians with two reminders: N=353 (71%) responded, 146 of whom did not manage people with acquired brain injury, leaving 207 questionnaires for analysis (Netherlands N=121, UK N=86). Descriptive summary statistics were compiled. Categorical and dichotomous data were compared between the groups using chi-squared tests.
RESULTS: Sixty-seven (78%) of British respondents served a predominantly younger adult (65 years) population, compared with only 27 (22%) of the Dutch, who mainly treated patients of all ages. In line with their respective guidelines, more British respondents reported that they screened all acquired brain injury patients for depression (68/86 (79%) British versus 71/121 (59%) Dutch, P<0.01), and used formal measures (37/68 (54%) versus 14/69 (20%), P<0.001). They also took a more active role in treatment of depression: only 1 (1%) never used antidepressants, compared with 22 (18%) of Dutch respondents (P<0.001). On the other hand, where antidepressants were prescribed, the Dutch respondents were more likely than the British to follow-up their patients (93/98 (95%) versus 67/84 (80%), P<0.01).
CONCLUSIONS: The survey demonstrates a broadly similar approach, but highlights some significant variance in practice between the two countries which may stem from differences in population and service provision as well as their respective guidelines.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17875560     DOI: 10.1177/0269215507079129

Source DB:  PubMed          Journal:  Clin Rehabil        ISSN: 0269-2155            Impact factor:   3.477


  1 in total

1.  Cognitive Impairment after Severe Traumatic Brain Injury, Clinical Course and Impact on Outcome: A Swedish-Icelandic Study.

Authors:  Maud Stenberg; Alison K Godbolt; Catharina Nygren De Boussard; Richard Levi; Britt-Marie Stålnacke
Journal:  Behav Neurol       Date:  2015-12-09       Impact factor: 3.342

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.